Inosiplex for treatment of alopecia areata: A randomized placebo-controlled study

Acta Dermato-Venereologica

Volumn 86, Issue 5, 2006, Pages 422-424

  Georgala, Sofia ^a,b   Katoulis, Alexander C ^a   Befon, Angeliki ^a   Georgala, Katerina ^a   Stavropoulos, Panagiotis G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

Alopecia areata; Immunomodulation; Inosine pranobex; Isoprinosine; Systemic therapy

Indexed keywords

CORTICOSTEROID; DITHRANOL; METHISOPRINOL; MINOXIDIL; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ALOPECIA AREATA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INOSINE PRANOBEX; MALE;

EID: 33748991995     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0138     Document Type: Article

References (19)

1. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2001; 45: 640-642.
2. Galbraith GM, Thiers BH, Fudenberg HH. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency. J Am Acad Dermatol 1984; 11: 224-230.
3. Lowy M, Ledoux Corbusier M, Achten G, Wybran J. Clinical and immunologic response to isoprinosine in alopecia areata and alopecia universalis: Association with autoantibodies. J Am Acad Dermatol 1985; 12: 78-84.
4. Galbraith GM, Thiers J, Hochler F. A randomized double-blind study of inosiplex (Isoprinosine) therapy in patients with alopecia totalis. J Am Acad Dermatol 1987; 16: 977-983.
5. Berth-Jones J, Hutchinson PE. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clin Exp Dermatol 1991; 16: 172-175.
6. Friedmann PS. Alopecia areata and autoimmunity. Br J Dermatol 1981; 105: 153-157.
7. Tobin DJ, Hann SK, Song MS, Bystryn JC. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol 1997; 133: 57-61.
8. Majewski BBJ, Koh MS, Taylor DR, Watson B, Rhodes EL. Increased ratio of helper-to-suppressor T cells in alopecia areata. Br J Dermatol 1984; 110: 171-175.
9. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998; 101: 62-67.
10. Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 1992; 31: 186-189.
11. Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R. Cytokines and growth factors influence hair growth in vitro: possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 1996; 288: 153-156.
12. Van der Steen P, Boezeman J, Duller P, Happle R. Can alopecia areata be triggered by emotional stress? Acta Derm Venereol 1992; 72: 279-280.
13. Ericson M, Binstock K, Guanche A, Hordinsky M. Differential expression of substance P in perifollicular scalp blood vessels and nerves after topical therapy with capsaicin 0.075% (Zostrix HP) in controls and patients with extensive alopecia areata. J Invest Dermatol 1999; 112: 653.
14. Campoli-Richards DM, Sorkin EM, Heel RC. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1986; 32: 383-424.
15. Wybran J, Faman JP, Gortz R. Inosiplex (Isoprinosine): a review of its immunological and clinical effects in disease. Adv Pharmacol Ther 1982; 6: 123-131.
16. Wybran J, Govaerts A, Appleboom T. Inosiplex a stimulating agent for normal human T cells and human leukocytes. J Immunol 1978; 121: 1184-1187.
17. Hadden JW, Hadden EM, Coffey RG. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation. Infect Immun 1976; 13: 382-387.
18. Ballet JJ, Morin A, Schmitt C, Agrapart M. Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen. Int J Immunopharmacol 1982; 4: 151-157.
19. Morin A, Ballet JJ. A recent review on in vitro and in vivo immunological activities of methisoprinol. Allergol Immunopathol (Madrid) 1982; 10: 109-114.